ArticleFrontiers in pharmacology2022

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma.

Can Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.